Open AccessResearch Into the Effect of Proton Pump Inhibitors on Lungs and Leukocytes
Author(s) -
Orhan Özatik,
Fikriye Yasemin Özatik,
Yasemin Tekşen,
İlknur Dağ,
Suna Sayğılı,
Ahmet Koçak
Publication year - 2021
Publication title -
pubmed central
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 28
ISSN - 1300-4948
DOI - 10.5152/tjg.2021.20550
Subject(s) - medicine , superoxide dismutase , lung , myeloperoxidase , immunohistochemistry , catalase , pathology , glutathione peroxidase , pharmacology , inflammation , staining , immunology , gastroenterology , oxidative stress
Proton pump inhibitors (PPI) are the most commonly used medication in the world. They are prescribed as an effective treatment choice for gastrointestinal system diseases linked to hyperacidity, especially. Additionally, non-indication and unnecessary use are very common. Many publications in recent times have reported significant side effects. However, there are insufficient studies about the mechanism for these side effects.